Conférences  >  Médecine & Soins de Santé  >  Cancérologie  >  Italie

The European Association for Cancer Research (EACR) and The Mark Foundation for Cancer Research

Early-onset cancers are rising globally. Cancers typically associated with those over the age of 50 are increasingly being diagnosed in young adults. How to prevent and treat these tumours is still unknown. This conference aims to foster a deeper understanding of the biological mechanisms, risk factors, and clinical implications of early-onset cancers. By bringing together leading experts from diverse fields in cancer research, the meeting will provide a unique platform to discuss the latest discoveries about early-onset cancers, promoting interdisciplinary collaboration and identifying strategies for early detection, prevention, and treatment. Special attention will be given to knowledge gaps, translational studies and healthcare disparities, and towards improving the clinical management of early-onset cancer patients. The target audience for this conference is researchers and physicians who are interested in the epidemiology and aetiology of sporadic cancers among younger adults to discuss key questions in the field and lay the foundations for generating a community dedicated to the study of early-onset cancers.

Conference Officer, Hannah Barrs;     Tél.: [N/A];     Email.: hannah.barrs@eacr.org

cancer research, oncology, early-onset cancers, biological mechanisms of cancer, cancer risk factors, clinical implications, early detection, prevention, cancer treatment, cancer therapies, healthcare disparities, translational cancer research, clinical management of cancer patients, cancer epidemiology, cancer aetiology, molecular pathology, exposome changes, cancer microbiome, cancer immunity, the tumour microenvironment, carcinogenesis, cancer epigenetics, preclinical experimental models, microsimulation modelling, cancer, cancer survivorship.

Biologie moléculaire,    Biologie des systèmes

The European Association for Cancer Research (EACR)

Designing efficient novel therapeutics cannot be achieved without understanding the dynamics of the tumour microenvironment or of reciprocal cancer-stroma interactions and how they are modulated by cancer treatments. With this in mind, the second edition of this conference topic will cover the latest exciting breakthroughs in this field. Specialist themes include the intricate interactions of cancer cells with the immune system and with specific stromal cells in multiple organs, novel insights into tumour-host interactions including the nervous system, and response to therapy. If you’re interested in translational cancer biology, immunology, and therapeutics – whether you’re a scientist, postdoc, graduate student, industry scientist, or journal editor – then this conference is not to be missed. Submit your application by 19 January 2026 for the chance to present your work and register by 16 February 2026 to join us in Bergamo.

Conference Officer: Hannah Barrs;     Email.: hannah.barrs@eacr.org

cancer research, oncology, tumour microenvironment, novel therapeutics, cancer cells, stromal cells, cancer-stroma interactions, cancer immunology, tumour-host interactions, treatment response